Inhibitory effects of Kampo medicines, Keishibukuryogan and Shakuyakukanzoto, on the substrate uptake activities of solute carrier organic anion transporters
The aim of this study was to assess the effects of Keishibukuryogan (K-06) and Shakuyakukanzoto (TJ-68), commercial herbal medicines, on the substrate uptake activities of renal organic anion transporters. We performed transporter uptake and cell viability assays in Xenopus oocytes and HEK293 human...
Main Authors: | Ho-Sung Lee, Ho Jung Shin, Munju Cho, Seung Hoon Lee, Dal-Seok Oh |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-12-01
|
Series: | Journal of Pharmacological Sciences |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861318301944 |
Similar Items
-
Antinociceptive Effect of Shakuyakukanzoto, a Kampo Medicine, in Diabetic Mice
by: Yuji Omiya, et al.
Published: (2005-01-01) -
Identification of a Predictive Biomarker for the Beneficial Effect of Keishibukuryogan, a Kampo (Japanese Traditional) Medicine, on Patients with Climacteric Syndrome
by: Takao Namiki, et al.
Published: (2014-01-01) -
Effect of Keishibukuryogan, a Japanese Traditional Kampo Prescription, on Improvement of Microcirculation and Oketsu and Induction of Endothelial Nitric Oxide: A Live Imaging Study
by: Tsutomu Tomita, et al.
Published: (2017-01-01) -
Dual actions on gout flare and acute kidney injury along with enhanced renal transporter activities by Yokuininto, a Kampo medicine
by: Seung Hoon Lee, et al.
Published: (2019-03-01) -
Keishibukuryogan (Gui-Zhi-Fu-Ling-Wan), a Kampo Formula, Decreases Disease Activity and Soluble Vascular Adhesion Molecule-1 in Patients with Rheumatoid Arthritis
by: Kazuya Nozaki, et al.
Published: (2006-01-01)